![](https://agemanagementindia.com/wp-content/uploads/2021/04/Covaxin.jpg)
Similar Posts
![Analysis of Controversies with COVID-19](https://agemanagementindia.com/wp-content/uploads/2021/05/Analyses-of-Controversies-with-COVID-19_1-768x433.jpg)
Analysis of Controversies with COVID-19
Interview given by Ex Professor & Head Orthopaedic Department: Dr Ajay Gupta, Orthopaedic Surgeon, Maulana Azaad Medical College, LNJP Hospital VPBansal
![Corona Virus – COVID-19 Update](https://agemanagementindia.com/wp-content/uploads/2020/03/Coronavirus-COVID-19-update.jpg)
Corona Virus – COVID-19 Update
The U.S. Centers for Disease Control and Prevention is urging aged individuals and aged people with severe medical conditions such as heart, lung or kidney disease to “stay home as much as possible” and avoid crowds to avoid contracting the corona virus. The CDC updated the guidance on its COVID-19 website on Friday. The agency…
![Covid Vaccine Update](https://agemanagementindia.com/wp-content/uploads/2020/12/Covid-Vaccine-768x576.jpg)
Covid Vaccine Update
Oxford AstraZeneca vaccine could get approval in the UK and India next week Both the United Kingdom and India are expected to become the first countries to grant emergency regulatory approval for the AstraZeneca and Oxford University vaccine next week, according to a Reuters report. The vaccine, named Covishield by its manufacturers in the subcontinent,…